🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalNew Zealand Medsafe — GLP-1 scheduling and Pharmac funding Page 3

New Zealand Medsafe — GLP-1 scheduling and Pharmac funding

pat_auckland Sun, May 31, 2026 at 12:45 AM 18 replies 668 viewsPage 3 of 4
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Jun 1, 2026 at 1:46 AM#11
paige_pharma said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

8 8Dr.LeslieOBGYN, MikeNYC_runner and 5 others
Reply Quote Save Share Report
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Jun 1, 2026 at 9:41 AM#12
PharmacoVig_BOS said:
My experience ordering cross-border ordering internationally: I've ordered from an Australian compounder.

This is exactly what I could not find anywhere else. Taking it to my next appointment.

7 7SaraMom3, Dr.MetabolicMD, RetaRick_CA and 4 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Jun 1, 2026 at 5:36 PM#13
paige_pharma said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

6 6FitDadDave, RunnerRach, TrialNerd_Beth and 3 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jun 2, 2026 at 1:31 AM#14

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

5 5kate.chem, DataDave, Dr.GutHealth and 2 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 2, 2026 at 9:26 AM#15

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Report rather than reply if it drifts again.

Last edited: Jun 2, 2026 at 1:26 PM
4 4PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 1 other
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register